Brendon P Scicluna is an expert in Critical care at Mater Dei Hospital (Malta). As of October 2026, ScienceLeadR ranks Brendon P Scicluna in the top 1% of experts worldwide for Community-Acquired Pneumonia and Pneumonia. Brendon P Scicluna has authored 165 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 1 of them ongoing. SLR score: 584 (community average: 125). How the SLR is computed.

LeadR Profile

Brendon P Scicluna Mater Dei Hospital Malta
584 ScienceLeadR Reputation 584
Network Map

Critical care

Subspecialties: Pulmonology - Biochemistry - Infectiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2006 - 2026

Source: PubMed

University of Malta

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 165

Citations

Citations: 9 366 1st author: 15 Last author: 6 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Community-Acquired Pneumonia: Disease Course Prediction With a 5-Gene Signature.
PMID 42548383 — genes, mortality, pneumonia, prospective studies, gene expression, community-acquired pneumonia
CHEST Pulm20260
Disturbed metabolic adaptation drives natural killer cell dysfunction in association with nosocomial infection during human sepsis.
PMID 42361407 — nutrients, cells, killer cells, natural, biomedical research, food, sepsis, infections
EBioMedicine20261
Quantifying immune dysregulation in pneumonia and sepsis with a parsimonious machine-learning model: a multicohort analysis across care settings and reanalysis of a hydrocortisone randomised controlled trial.
PMID 41856148 — mortality, immunomodulation, biomarkers, machine learning, pneumonia, sepsis, therapeutics, learning, hydrocortisone, infections, plasma
Lancet Respir Med Top journal20260
Exploring blood transcriptional signatures for thrombosis diagnosis in critically ill patients with COVID-19.
PMID 41695759 — genes, blood, alpha-glucosidases, neutrophil activation, neutrophils, biomarkers, covid-19, critical illness, diagnosis, thrombosis
Blood Vessel Thromb Hemost20260
Control of renal central carbon metabolism by heme oxygenase-1.
PMID 41550715 — heme oxygenase-1, stress, physiological, oxygenases, kidney, heme, heme oxygenase (decyclizing)
iScience20250

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 4
Phase 1 2
Phase 3 1

By status:

Completed 4
Unknown 2
Recruiting 1

By type:

Observational 4
Interventional 3

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 7

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Molecular Subtype Specific Mechanisms and Therapeutic Strategies in Sepsis
NCT06287684 — toxemia, shock, septic, sepsis, therapeutics
N/ARecruiting2023

LeadR Networks

Main global connection map